Sage Journals: Discover world-class research

Abstract

Background

Reduction in gadolinium (Gd) contrast agents is wanted due to the uncertainty of the potential side effects.

Purpose

To investigate whether it is possible to reduce the contrast dose from conventional double dose to single dose when increasing the field strength from 1.5-T to 3-T for separating early cartilage degeneration from healthy cartilage, assessed by delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC).

Material and Methods

Nine patients with knee osteoarthritis (OA), Kellgren–Lawrence grade (KLG) 1–4, were recruited from an ongoing weight loss cohort study. dGEMRIC was performed at 3-T using single (0.1 mmoI/kg) and double (0.2 mmoI/kg) doses of intravenous (i.v.) Gd-DTPA^2-. Regions of interest (ROls) were drawn around the posterior weight-bearing femoral knee cartilage in lateral and medial compartments. In five medial compartments ROIs could not be drawn due to severe degeneration of cartilage. T1-relaxation times were compared to previously published values from 1.5-T and to non-contrast values from 3-T.

Results

Mean dGEMRIC T1-relaxation time in the lateral compartment was 769 ms for single dose vs. 561 ms for double dose (P < 0.0001); and 685 ms for single dose vs. 454 ms for double dose (P = 0.004) in the medial compartment.

Conclusion

We found a dose-response relationship between single and double doses of Gd-DTPA^2- using 3-T in knee OA patients, similar to the findings at 1.5-T. Compared to the T1-relaxation time at 3-T without contrast (1240 ms), this further separation between OA and normal cartilage indicates that “single dose” dGEMRIC could be sufficient for cartilage health assessment at 3-T.

Keywords

Knee osteoarthritis MRI cartilage dGEMRIC Gd-dosage

Get full access to this article

View all access options for this article.

References

Hunter

DJ.

Osteoarthritis.

Best Pract Res Clin Rheumatol 2011; 25:801–814.

Carr

Robertsson

Graves

et al . Knee replacement. Lancet 2012; 379:1331–1340.

Gandy

Dieppe

Keen

et al . No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage 2002; 10:929–937.

Peterfy

Gold

Eckstein

et al . MRI protocols for whole-organ assessment of the knee in osteoarthritis. Osteoarthritis Cartilage 2006; 14:95–111.

Eckstein

Kunz

Schutzer

et al . Two year longitudinal change and test-retest-precision of knee cartilage morphology in a pilot study for the osteoarthritis initiative. Osteoarthritis Cartilage 2007; 15:1326–1332.

Eckstein

Buck

Wyman

et al . Quantitative imaging of cartilage morphology at 3.0 Tesla in the presence of gadopentate dimeglumine (Gd-DTPA). Magn Reson Med 2007; 58:402–406.

Bashir

Gray

Burstein

Gd-DTPA2- as a measure of cartilage degradation.

Magn Reson Med 1996; 36:665–673.

Burstein

Velyvis

Scott

et al . Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001; 45:36–41.

Pakin

Schweitzer

et al . Rapid 3D-T1rho mapping of the knee joint at 3.0T with parallel imaging. Magn Reson Med 2006; 56:563–571.

10.

Benjamin Ma

Link

et al . In vivo T(1rho) and T(2) mapping of articular cartilage in osteoarthritis of the knee using 3 T MRI. Osteoarthritis Cartilage 2007; 15:789–797.

11.

Blumenkrantz

Majumdar

Quantitative magnetic resonance imaging of articular cartilage in osteoarthritis.

Eur Cell Mater 2007; 13:76–86.

12.

Bashir

Gray

Hartke

et al . Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 1999; 41:857–865.

13.

Williams

Mikulis

Krishnan

et al . Suitability of T(1Gd) as the dGEMRIC index at 1.5T and 3.0T. Magn Reson Med 2007; 58:830–834.

14.

Tiderius

Olsson

de Verdier

et al . Gd-DTPA2-Enhanced MRI of femoral knee cartilage: A dose-response study in healthy volunteers. Magn Reson Med 2001 1; 46:1067–1071.

15.

Darrah

Prutsman-Pfeiffer

Poreda

et al . Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 2009; 1:479–488.

16.

Kanda

Ishii

Kawaguchi

et al . High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2013; 270:834–841.

17.

Runge

VM.

Safety of the gadolinium-based contrast agents for magnetic resonance imaging, focusing in part on their accumulation in the brain and especially the dentate nucleus.

Invest Radiol 2016;51:273–279.

18.

European Medicines Agency. EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans. London: EMA, 2017. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/gadolinium_contrast_agents_31/European_Commission_final_decision/WC500240575.pdf

19.

Kellgren

Lawrence

JS.

Radiological assessment of osteo-arthrosis.

Ann Rheum Dis 1957; 16:494–502.

20.

Tiderius

Tjörnstrand

Aakeson

et al . Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): Intra- and interobserver variability in standardized drawing of regions of interest. Acta Radiol 2004; 45:628–634.

21.

Wang

Regatte

RR.

Quantitative mapping of human cartilage at 3.0T: parallel changes in T2, T1rho, and dGEMRIC.

Acad Radiol 2014; 21:463–471.

22.

Gold

Han

Stainsby

et al . Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. Am J Roentgenol 2004; 183:343–351.

23.

Rehnitz

Kupfer

Streich

et al . Comparison of biochemical cartilage imaging techniques at 3 T MRI. Osteoarthritis Cartilage 2014; 22:1732–1742.

24.

Guermazi

Alizai

Crema

et al . Compositional MRI techniques for evaluation of cartilage degeneration in osteoarthritis. Osteoarthritis Cartilage 2015; 23:1639–1653.

25.

Owman

Tiderius

Neuman

et al . Association between findings on delayed gadolinium-enhanced magnetic resonance imaging of cartilage and future knee osteoarthritis. Arthritis Rheum 2008; 58:1727–1730.

26.

Crema

Hunter

Burstein

et al . The relationship between the Kellgren-Lawrence grade of radiographic knee osteoarthritis and delayed gadolinium-enhanced MRI of medial tibiofemoral cartilage (DGEMRIC): a 1-year follow-up study. Osteoarthritis Cartilage 2013; 21:179–180.

27.

Bittersohl

Hosalkar

Hesper

et al . Advanced imaging in femoroacetabular impingement: current state and future prospects. Front Surg 2015; 2:34.

28.

Boesen M, Jensen KE, Qvistgaard E, et al. Delayed gadolinium-enhanced magnetic resonance imaging (dGEMRIC) of hip joint cartilage: better cartilage delineation after intra-articular than intravenous gadolinium injection. Acta Radiol 2006;47(4):391–396.

29.

Hangaard S, Gudbergsen H, Skougaard M, et al. Point of no return for improvement of cartilage quality indicated by dGEMRIC before and after weight loss in patients with knee osteoarthritis: a cohort study. Acta Radiol 2018;59(3):336–340.

Single- vs. double-dose gadolinium contrast in delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in knee osteoarthritis: is dose reduction possible on 3-T MRI?

Abstract

Background

Purpose

Material and Methods

Results

Conclusion

Keywords

Get full access to this article

References